We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader. Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Company Implemented Significant...
Company implementing a series of cost-savings measures designed to extend Salariusโ expected cash runway into the first half of 2025 Extended runway supports the generation of additional data...
Expands IP portfolio with composition-of-matter protection into 2039 for novel molecular glues Protein degrader portfolio now includes 17 issued patents across six patent families HOUSTON, Jan...
HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that the hematologic cancer Phase 1/2 clinical trial being conducted at the University of Texas...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0139 | 2.88861180382 | 0.4812 | 0.52 | 0.4754 | 18058 | 0.50698917 | CS |
4 | -0.0615 | -11.0492274524 | 0.5566 | 0.56 | 0.43 | 41296 | 0.48893862 | CS |
12 | -0.0469 | -8.65313653137 | 0.542 | 0.7888 | 0.43 | 117896 | 0.53632141 | CS |
26 | -0.2299 | -31.7103448276 | 0.725 | 0.93 | 0.43 | 73664 | 0.57101373 | CS |
52 | -1.1549 | -69.9939393939 | 1.65 | 2.31 | 0.43 | 78688 | 0.9641482 | CS |
156 | -30.0049 | -98.3767213115 | 30.5 | 37.75 | 0.43 | 505953 | 17.1642221 | CS |
260 | -288.2549 | -99.8285367965 | 288.75 | 370.385 | 0.43 | 573153 | 28.60709435 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions